Although clinically distinct, psoriasis and IBD share core pathogenic mechanisms, including immune dysregulation, Th17-mediated inflammation, and overlapping susceptibility loci such as IL23R and IL12B [10,11,12]. This evidence concerns the gene IL23R and inflammatory bowel disease.